Thyroid cancer diagnoses have spiked for U.S. women this past decade. That’s why it’s essential to pay attention to this small gland at the base of your neck. The thyroid is an important part of your endocrine...

Cervical cancer is the only gynecologic cancer that can be prevented, yet there were more than 4,000 deaths in the United States in 2021 and nearly 14,500 new cases, the American Cancer Society says. The best way...

The Supreme Court began to hear oral arguments on Friday as it weighs whether the Biden administration can enforce vaccine mandates for large companies. The justices are also hearing arguments on a separate vaccine mandate for most...

A review of cases from 465 U.S. hospitals underscores the protection provided by COVID-19 vaccines. The new review — by researchers at the U.S. National Institutes of Health — found that vaccinated adults who got breakthrough infections...

When it comes to what makes us happy, is reading or listening to music any better than spending hours playing video games? Not really, says a team of researchers from the United Kingdom and Austria. “Many people...

It is the ultimate irony: More COVID-19 treatments exist now than at any other time during the pandemic, but the skyrocketing number of cases from the surging Omicron variant might mean you can’t get them when you...

Getting vaccinated against COVID-19 may slightly and temporarily extend the time between a woman’s menstrual periods, a new study reports. On average, researchers found that the extra time amounts to slightly less than one day. It’s something...

FRIDAY, Jan. 7, 2022 (American Heart Association News) — Kelly Fucheck woke up one summer Sunday ready to spend a quiet morning at home with her husband, Glen. Their toddler, Tomas, had spent the night at grandma’s...

Citing the rapid spread of the Omicron variant and the need for protection against it, U.S. federal health officials are shortening the recommended time between the second dose of the Moderna vaccine and a booster shot from...

Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price...